According to the GuruFocus All-in-One Screener as of Sep. 10, the following healthcare stocks are popular among gurus.
Johnson & Johnson
Johnson & Johnson (JNJ) has a market cap of $391.21 billion. Its revenue of $80.5 billion has increased 2.90% over the past 10 years.
The company is held by 30 gurus, including Pioneer Investments (Trades, Portfolio) with 0.23% of outstanding shares, Jeremy Grantham (Trades, Portfolio) with 0.09% and Jim Simons (Trades, Portfolio)' Renaissance Technologies with 0.09%.
As of Sep. 10, the stock was trading with a price-earnings ratio of 26.11. The share price of $148.59 was 5.36% below the 52-week high and 36.12% above the 52-week low. Over the past decade, the stock has gained 148%.
Merck & Co
Merck & Co. Inc. (MRK) has a market cap of $215.59 billion. Its revenue of $47 billion has increased 1.20% over the past five years.
Among the 29 gurus invested in the company, Ken Fisher (Trades, Portfolio) is the largest shareholder with 0.36% of outstanding shares, followed by Pioneer Investments (Trades, Portfolio) with 0.35% and the Vanguard Health Care Fund (Trades, Portfolio) with 0.23%.
As of Sep. 10, the stock was trading with a price-earnings ratio of 20.79. The share price of $85.24 was 7.99% below the 52-week high and 30.64% above the 52-week low. Year to date, the stock has gained 136%.
Pfizer
Pfizer Inc. (PFE) has a market cap of $202.05 billion. Its revenue of $49 billion has decreased 1.10% over the past decade.
The company is held by 21 gurus. The largest guru shareholder is the Vanguard Health Care Fund (Trades, Portfolio) with 1.30% of outstanding shares. Other notable shareholders include Diamond Hill Capital (Trades, Portfolio) with 0.16% and Pioneer Investments (Trades, Portfolio) with 0.14%.
As of Sep. 10, shares were trading with a price-earnings ratio of 14.43. The share price of $36.36 was 11.25% below the 52-week high and 30.42% above the 52-week low. Over the past decade, the stock has gained 116%.
Novartis
Novartis AG. (NVS) has a market cap of $198.11 billion. Its revenue of $49.52 billion has fallen 0.70% over the past 10 years.
A total of 14 gurus hold the stock. With 1.02% of outstanding shares, PRIMECAP Management (Trades, Portfolio) is the largest guru shareholder, followed by Dodge & Cox with 0.85% and Fisher with 0.39%.
On Sep. 10, the stock traded with a price-earnings ratio of 26.32. The share price of $86.68 was 13.18% below the 52-week high and 25.30% above the 52-week low. Since July 2010, the stock has gained 83%.
Abbott
Abbott Laboratories (ABT) has a market cap of $184.42 billion. Its revenue of $31.42 billion has increased 0.50% over the past 10 years.
Twenty gurus own the stock. The company's largest guru shareholder is Vanguard Health Care Fund (Trades, Portfolio) with 0.84% of outstanding shares, followed by Fisher with 0.39% and PRIMECAP Management (Trades, Portfolio) with 0.38%.
On Sep. 10, the share price of $104.16 was 8.79% below the 52-week high and 69.06% above the 52-week low. The stock was trading with a price-earnings ratio of 60.21. Over the past 10 years, the stock has gained 326%.
Disclosure: I do not own any stocks mentioned.
Read more here:
- 5 Guru Stocks Boosting Earnings
- 5 Companies Expanding Book Value
- 6 Guru Stocks With High Dividend Yields
Not a Premium Member of GuruFocus? Sign up for a free 7-day trial here.
